News & Events

Our news posts are an easy way to keep up-to-date with all our latest developments. View the event posts to stay informed of all our upcoming events and activities.

Cellectricon’s expertise in pain research recognized by second EU research grant

MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has received follow-on funding for bone pain research...

Senior Scientist, high content imaging and analysis

Cellectricon is an innovative discovery services provider with a focus on the neurobiology of peripheral and central nervous system diseases....

New publication: A Microfluidic High-Capacity Screening Platform for Neurological Disorders

We are happy to announce the publication of “A Microfluidic High-Capacity Screening Platform for Neurological Disorders”. In the paper, published...

Sign up to get news & events updates from Cellectricon

Cellectricon is looking for a scientist to join our team

Cellectricon is an innovative services provider dedicated to advancing drug discovery and research in the areas of peripheral neuropathies, neuroplasticity...

Cellectricon receives CIR (French Research Tax Credit) accreditation

MÖLNDAL, SWEDEN Cellectricon AB, a services provider dedicated to advancing neuroscience drug discovery, today announced that it has received CIR...

Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services

Mölndal, Sweden Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of a new service...

Sign up to get news & events updates from Cellectricon

Delix Therapeutics partners with Cellectricon, Expressive Neuroscience and expands science team to accelerate drug discovery and translatability

We’re excited to be working with Delix Therapeutics and support their development of neuroplasticity-promoting therapeutics! At Cellectricon, we solve our...

Cellectricon strengthens IP portfolio – Receives “Intention to Grant” from the European Patent Office

Cellectricon AB, a leading provider of neurobiology in vitro research services, today announced that the company received notice of intention...

Cellectricon receives funding from Takeda’s open innovation platform

March 3, 2021 Cellectricon, a leading provider of neurobiology in vitro research services, is delighted to announce the initiation of...